ZIP12 (zinc transporter)

Class

Anti-ZIP12 monoclonal antibody

ZIP12 (gene SLC39A12) belongs to the ZIP (Zrt/Irt-like protein) family of zinc transporters that move zinc ions from the extracellular space into the cytoplasm, raising the pool of free intracellular zinc available for signaling and enzymatic reactions. Zinc functions both as a structural cofactor and as a second messenger, influencing pathways that govern cell growth, survival, and gene transcription. ZIP12 is normally expressed in a limited set of tissues, including brain and vascular tissue, but its expression rises sharply under low-oxygen conditions because its gene is a direct target of hypoxia-inducible transcription factors. In pulmonary blood vessels, this hypoxia-driven increase in ZIP12 raises intracellular zinc within smooth muscle cells, promoting their proliferation and contributing to thickening and remodeling of the vessel wall, a hallmark of pulmonary arterial hypertension. Because ZIP12 sits on the cell surface and its elevated expression is largely confined to diseased, oxygen-deprived tissue, it offers a mechanism-specific handle for interrupting one driver of vascular remodeling without broadly disturbing systemic zinc metabolism. A monoclonal antibody directed against ZIP12 aims to block its zinc-importing function or reduce its surface abundance, potentially limiting smooth muscle proliferation in chronic pulmonary vascular disease and other hypoxia-driven remodeling conditions.